Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biocon
Biotech
Equillium adds 3 drugs to pipeline via $329M Bioniz buy
Equillium will dole out up to $329 million to bring Bioniz's three drugs into the fold. Its new pipeline now includes lymphoma, alopecia and more.
Kyle LaHucik
Feb 16, 2022 7:00am
Bicara debuts with $40M to bankroll bifunctional antibodies
Mar 15, 2021 7:00am
Ex-Genzyme CFO Sherblom joins ReForm as chair—Chutes & Ladders
Mar 5, 2021 9:30am
Mylan seeks FDA approval for biosimilar Herceptin copy
Nov 8, 2016 9:22am
Indian CRO Syngene sets up Amgen R&D center in Bangalore
Sep 6, 2016 11:13am
Bristol-Myers Squibb pulls out of Biocon oral insulin pact
May 17, 2016 8:12am